We describe reagents from 2 workshops which had been identified as recognizing the same or very similar antigens based on their tissue reactivity. Examination of their tissue specificity led us to the conclusion that this was similar to the expression of the neural cell adhesion molecule (NCAM). We
Monoclonal antibody UJ13A recognizes the neural cell adhesion molecule (NCAM)
β Scribed by K. Patel; R. J. Rossell; S. Bourne; S. E. Moore; F. S. Walsh; J. T. Kemshead
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 1006 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The purpose of this investigation was to determine the targeting potential of the murine monoclonal antibody (MAb) RNL-I for human small-cell lung cancer (SCLC) in a nude mouse model. RNL-I is preferentially reactive with SCLC and lung carcinoids, and was classified as a cluster-I MAb as defined by
Monoclonal antibodies (MAbs) ranked together as small-celllung-cancer (SCLC) Cluster I MAbs are directed against the neural cell adhesion molecule NCAM (CD 56) and have been shown to be useful reagents in SCLC diagnosis and therapy. We analyzed the epitopes recognized by 5 SCLC cluster-I MAbs (I 23C
A monoclonal antibody (mAb), 2E12, against the neural cell adhesion molecule L1 recognized the 200 kDa component of L1. The epitope of L1 reacting with mAb 2E12 was localized in its carbohydrate chain, judging from the results o C experiments on glycopeptidase F treatment. The physiological effect o
## Abstract In rodents, chronic stress induces longβlasting structural and functional alterations in the hippocampus, as well as learning and memory impairments. The neural cell adhesion molecule (NCAM) was previously hypothesized to be a key molecule in mediating the effects of stress due to its r